Back to Results
First PageMeta Content
Clinical research / Design of experiments / Organochlorides / Clinical trial / Pharmaceutical industry / Pharmacology / Ondansetron / Schizophrenia / Desvenlafaxine / Psychiatry / Chemistry / Medicine


N022117 Asenapine Amend 4
Add to Reading List

Open Document

File Size: 229,90 KB

Share Result on Facebook

City

Rockville / Washington / DC / Jersey City / Reference / /

Company

NDA 022117 Forest Laboratories Inc. / Forest Laboratories Inc. / /

/

Event

FDA Phase / /

Facility

Columbia University / Robert Temple / /

IndustryTerm

clinical protocols / clinical protocol / /

MedicalCondition

treatment-resistant childhood-onset schizophrenia / childhood onset schizophrenia / adult onset schizophrenia / chronic and debilitating illness / Pediatric Mania / psychotic disorders / either schizophrenia / Pediatric Schizophrenia Schizophrenia / disorder / Pediatric Schizophrenia / developmental language disorders / adult schizophrenia / Mental Disorders / pervasive developmental disorders / adolescent schizophrenia / adult and adolescent schizophrenia / Pediatric Bipolar Disorder / schizophrenia / disease / I Disorder / personality disorder / posttraumatic stress disorder / Mania / adult and pediatric bipolar disorder / accurately diagnosing schizophrenia / schizophrenic psychoses / same disease / childhood schizophrenia / dyskinesias / mood disorder / disorders / bipolar disorder / /

MedicalTreatment

clinical protocol / clinical protocols / /

Organization

Bibliography American Academy of Child and Adolescent Psychiatry / Columbia University / Food and Drug Administration / Data Safety Monitoring Board / Division of Psychiatry Products / American Psychiatric Association / office of Generic Drugs / DEPARTMENT OF HEALTH AND HUMAN SERVICES / DEPARTMENT OF HEALTH / American Academy of Child and Adolescent Psychiatry / Center for Drug Evaluation / /

Person

Debleena Sengupta / Silver Spring / Sharonjit Sagoo / Kelly Posner / /

/

Position

investigator / e.g. child psychiatrist / Director / Regulatory Affairs Harborside Financial Center Plaza / PEDIATRIC BIPOLAR DISORDER General / messenger / Regulatory Project Manager / Deputy Director Office / author / Governor / Director / PEDIATRIC SCHIZOPHRENIA General / /

Product

Sublingual Tablets / Developing / Human Drug / /

ProvinceOrState

New Jersey / Maryland / /

PublishedMedium

the Past 10 Years Journal / American Journal of Psychiatry / /

Technology

alpha / clinical protocol / clinical protocols / /

SocialTag